Fa-Jun Nan

537 total citations
18 papers, 470 citations indexed

About

Fa-Jun Nan is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Fa-Jun Nan has authored 18 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 8 papers in Organic Chemistry. Recurrent topics in Fa-Jun Nan's work include Peptidase Inhibition and Analysis (13 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Neuropeptides and Animal Physiology (6 papers). Fa-Jun Nan is often cited by papers focused on Peptidase Inhibition and Analysis (13 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Neuropeptides and Animal Physiology (6 papers). Fa-Jun Nan collaborates with scholars based in China and United States. Fa-Jun Nan's co-authors include Jing-Ya Li, Qi-Zhuang Ye, Ling‐Ling Chen, Jia Li, Qun‐Li Luo, Qingqing Huang, Min Gu, Xing-Zu Zhu, Yahui Zhang and Dazhi Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Fa-Jun Nan

18 papers receiving 465 citations

Peers

Fa-Jun Nan

ONCOL

CMN

EPIDE

Darrin Dabideen United States

RINZO NISHIZAWA Japan

Walajapet G. Rajeswaran United States

Béatrice Bonnet France

Kiran S. Toti United States

Alan S. Florjancic United States

Ashok C. Bajji United States

Anikó Göblyös Netherlands

Xiao Ge China

Si-Tu Xue China

Darrin Dabideen United States

Fa-Jun Nan

122 ×0.5

34 ×0.2

ONCOL

159 ×0.8

108 ×0.8

CMN

16 ×0.2

EPIDE

Citations per year, relative to Fa-Jun Nan Fa-Jun Nan (= 1×) peers Darrin Dabideen

Countries citing papers authored by Fa-Jun Nan

Since Specialization

Citations

This map shows the geographic impact of Fa-Jun Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fa-Jun Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fa-Jun Nan more than expected).

Fields of papers citing papers by Fa-Jun Nan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fa-Jun Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fa-Jun Nan. The network helps show where Fa-Jun Nan may publish in the future.

Co-authorship network of co-authors of Fa-Jun Nan

This figure shows the co-authorship network connecting the top 25 collaborators of Fa-Jun Nan. A scholar is included among the top collaborators of Fa-Jun Nan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fa-Jun Nan. Fa-Jun Nan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Zhou, Pingzheng, et al.. (2013). Discovery of a retigabine derivative that inhibits KCNQ2 potassium channels. Acta Pharmacologica Sinica. 34(10). 1359–1366. 13 indexed citations

Zhou, Pingzheng, Haibo Yu, Min Ji Gu, et al.. (2013). Phosphatidylinositol 4,5-bisphosphate alters pharmacological selectivity for epilepsy-causing KCNQ potassium channels. Proceedings of the National Academy of Sciences. 110(21). 8726–8731. 36 indexed citations

Huang, Qingqing, et al.. (2007). Structural analysis of inhibition of E. coli methionine aminopeptidase: implication of loop adaptability in selective inhibition of bacterial enzymes. BMC Structural Biology. 7(1). 84–84. 8 indexed citations

Huang, Min, et al.. (2007). Inhibition of Monometalated Methionine Aminopeptidase: Inhibitor Discovery and Crystallographic Analysis. Journal of Medicinal Chemistry. 50(23). 5735–5742. 20 indexed citations

Xu, Jie, Dazhi Liu, Jing-Ya Li, et al.. (2006). Design and synthesis of a biotin-tagged photoaffinity probe of paeoniflorin. Bioorganic & Medicinal Chemistry Letters. 16(12). 3306–3309. 6 indexed citations

Chen, Yihua, Yahui Zhang, Dazhi Liu, et al.. (2006). Design, Synthesis, and Biological Evaluation of Isoquinoline-1,3,4-trione Derivatives as Potent Caspase-3 Inhibitors. Journal of Medicinal Chemistry. 49(5). 1613–1623. 114 indexed citations

Liu, Gang, et al.. (2006). Facile synthesis of versatile functionalized amino caprolactams using RCM reactions of α-amino acrylamide. Tetrahedron Letters. 47(19). 3295–3298. 20 indexed citations

Huang, Qingqing, Jie Xu, Ling‐Ling Chen, et al.. (2005). Identification of potent type I MetAP inhibitors by simple bioisosteric replacement. Part 1: Synthesis and preliminary SAR studies of thiazole-4-carboxylic acid thiazol-2-ylamide derivatives. Bioorganic & Medicinal Chemistry Letters. 15(16). 3732–3736. 15 indexed citations

Huang, Qingqing, Jie Xu, Ling‐Ling Chen, et al.. (2005). Identification of potent type I MetAPs inhibitors by simple bioisosteric replacement. Part 2: SAR studies of 5-heteroalkyl substituted TCAT derivatives. Bioorganic & Medicinal Chemistry Letters. 15(18). 4130–4135. 16 indexed citations

10.

Huang, Qingqing, Min Huang, Fa-Jun Nan, & Qi-Zhuang Ye. (2005). Metalloform-selective inhibition: Synthesis and structure–activity analysis of Mn(II)-form-selective inhibitors of Escherichia coli methionine aminopeptidase. Bioorganic & Medicinal Chemistry Letters. 15(24). 5386–5391. 31 indexed citations

11.

Li, Jing-Ya, et al.. (2004). Characterization of Full Length and Truncated Type I Human Methionine Aminopeptidases Expressed from Escherichia coli. Biochemistry. 43(24). 7892–7898. 22 indexed citations

12.

Luo, Qun‐Li, Jing-Ya Li, Ling‐Ling Chen, et al.. (2004). Inhibitors of type I MetAPs containing pyridine-2-carboxylic acid thiazol-2-ylamide. Part 2: SAR studies on the pyridine ring 3-substituent. Bioorganic & Medicinal Chemistry Letters. 15(3). 639–644. 7 indexed citations

13.

Luo, Qun‐Li, Jing-Ya Li, Ling‐Ling Chen, et al.. (2004). Inhibitors of type I MetAPs containing pyridine-2-carboxylic acid thiazol-2-ylamide. Part 1: SAR studies on the determination of the key scaffold. Bioorganic & Medicinal Chemistry Letters. 15(3). 635–638. 18 indexed citations

14.

Li, Jing-Ya, et al.. (2004). Design and synthesis of chromogenic thiopeptolide substrates as MetAPs active site probes. Bioorganic & Medicinal Chemistry. 12(11). 2853–2861. 9 indexed citations

15.

Li, Jing-Ya, Ling‐Ling Chen, Min Gu, et al.. (2004). Mutations at the S1 Sites of Methionine Aminopeptidases from Escherichia coli and Homo sapiens Reveal the Residues Critical for Substrate Specificity. Journal of Biological Chemistry. 279(20). 21128–21134. 21 indexed citations

16.

Chen, Ling‐Ling, Jia Li, Jing-Ya Li, et al.. (2004). Type I methionine aminopeptidase from Saccharomyces cerevisiae is a potential target for antifungal drug screening.. PubMed. 25(7). 907–14. 6 indexed citations

17.

Li, Jing-Ya, Ling‐Ling Chen, Qun‐Li Luo, et al.. (2003). Specificity for inhibitors of metal-substituted methionine aminopeptidase. Biochemical and Biophysical Research Communications. 307(1). 172–179. 50 indexed citations

18.

Luo, Qun‐Li, Jing-Ya Li, Ling‐Ling Chen, et al.. (2003). Discovery and Structural Modification of Inhibitors of Methionine Aminopeptidases from Escherichia coli and Saccharomyces cerevisiae. Journal of Medicinal Chemistry. 46(13). 2631–2640. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact